The Serum Institute of India is producing the coronavirus vaccine developed by AstraZeneca Plc- Oxford is expecting the government to sign a formal supply and pricing agreement after the approval for emergency usage of the vaccine. 
Tune in as Rohini & Sachin discuss the takeaways from the conversation with Adar Poonawalla, CEO, Serum Institute of India